Elanco Animal Health (ELAN) Faces Scrutiny Over Delayed Product Launches – Hagens Berman

SAN FRANCISCO, July 15, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Elanco Animal Health Incorporated (NYSE: ELAN) investors who suffered substantial losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/elan Contact the Firm Now: ELAN@hbsslaw.com 844-916-0895 Investigation into Elanco Animal Health Incorporated (ELAN): Elanco Animal Health is facing questions from investors regarding the accuracy of its previous statements concerning the commercial launch timelines for two key products. ...